hAMSCs did not affect brain tumor cell proliferation (Figures 4a and b), in vivo Ki-67 (proliferative marker) expression in GBM (Supplementary Figure 8), or GBM expression of TNF-α, a necrosis marker (Supplementary Figure 8). This evidence concerns the gene TNF and glioblastoma.